Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

MRI measures of Alzheimer's disease and the AddNeuroMed study.

Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; AddNeuroMed Consortium..

Ann N Y Acad Sci. 2009 Oct;1180:47-55. doi: 10.1111/j.1749-6632.2009.05063.x.

PMID:
19906260
2.

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.

Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C.

Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82. doi: 10.1002/gps.2491.

PMID:
21157852
3.

AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.

Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium.; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2011 Oct 1;58(3):818-28. doi: 10.1016/j.neuroimage.2011.06.065.

PMID:
21763442
4.

Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2011 Sep 15;58(2):469-80. doi: 10.1016/j.neuroimage.2011.05.083.

PMID:
21718788
5.

Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.

Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2015 Jan 1;104:398-412. doi: 10.1016/j.neuroimage.2014.10.002.

PMID:
25312773
6.

Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.

Westman E, Aguilar C, Muehlboeck JS, Simmons A.

Brain Topogr. 2013 Jan;26(1):9-23. doi: 10.1007/s10548-012-0246-x.

7.

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.

Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium..

Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023.

8.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium..

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022.

PMID:
20447732
9.

Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis.

Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium..

Neuroradiology. 2012 Sep;54(9):929-38. doi: 10.1007/s00234-012-1005-0.

10.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001. Review.

PMID:
26073027
11.

Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.

Li Y, Wang Y, Wu G, Shi F, Zhou L, Lin W, Shen D; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2012 Feb;33(2):427.e15-30. doi: 10.1016/j.neurobiolaging.2010.11.008.

12.

Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.

Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative..

Eur Radiol. 2010 Mar;20(3):674-82. doi: 10.1007/s00330-009-1581-5.

PMID:
19760240
13.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Review.

14.

Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease.

Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, Rueckert D, Soininen H, Lötjönen J; Alzheimer's Disease Neuroimaging Initiative..

PLoS One. 2011;6(10):e25446. doi: 10.1371/journal.pone.0025446.

15.

The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.

Cavedo E, Redolfi A, Angeloni F, Babiloni C, Lizio R, Chiapparini L, Bruzzone MG, Aquino D, Sabatini U, Alesiani M, Cherubini A, Salvatore E, Soricelli A, Vernieri F, Scrascia F, Sinforiani E, Chiarati P, Bastianello S, Montella P, Corbo D, Tedeschi G, Marino S, Baglieri A, De Salvo S, Carducci F, Quattrocchi CC, Cobelli M, Frisoni GB.

J Alzheimers Dis. 2014;40(4):941-52. doi: 10.3233/JAD-132666.

PMID:
24577455
16.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI)..

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

17.

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.

Hua X, Lee S, Yanovsky I, Leow AD, Chou YY, Ho AJ, Gutman B, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2009 Dec;48(4):668-81. doi: 10.1016/j.neuroimage.2009.07.011.

18.

An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.

Schmitter D, Roche A, Maréchal B, Ribes D, Abdulkadir A, Bach-Cuadra M, Daducci A, Granziera C, Klöppel S, Maeder P, Meuli R, Krueger G; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage Clin. 2014 Nov 8;7:7-17. doi: 10.1016/j.nicl.2014.11.001.

19.

White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.

Lindemer ER, Salat DH, Smith EE, Nguyen K, Fischl B, Greve DN; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2015 Sep;36(9):2447-57. doi: 10.1016/j.neurobiolaging.2015.05.011.

20.

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.

Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage Clin. 2014 Nov 27;7:105-13. doi: 10.1016/j.nicl.2014.11.015.

Items per page

Supplemental Content

Support Center